tetano
Editor, Senior Moderator
Physiol Int
. 2022 Feb 28.
doi: 10.1556/2060.2022.00172. Online ahead of print.
COVID-19 infection in patients with chronic obstructive pulmonary disease: From pathophysiology to therapy. Mini-review
Monika Fekete[SUP] 1 [/SUP], Zsofia Szarvas[SUP] 1 [/SUP], Vince Fazekas-Pongor[SUP] 1 [/SUP], Agnes Feher[SUP] 1 [/SUP], Norbert Dosa[SUP] 1 [/SUP], Andrea Lehoczki[SUP] 2 [/SUP], Stefano Tarantini[SUP] 1 3 [/SUP], Janos Tamas Varga[SUP] 4 [/SUP]
Affiliations
Abstract
Introduction: Patients with chronic obstructive pulmonary disease (COPD) are a vulnerable group in terms of the outcome of coronavirus infection in relation to their disease or its treatment, with a higher risk of developing serious complications compared to the healthy population.
Aim: The aim of our summary study is to review the background and health outcomes of chronic obstructive pulmonary disease and COVID-19 infection in the presence of both diseases.
Methods: Review of national and international medical databases (PubMed, MEDLINE, and MOB) with keywords COPD, COVID-19, disease risk, cause, prevention, complications, and prognosis.
Results: Meta-analyses show that COPD is one of the most common underlying conditions in patients hospitalized for COVID-19. Such patients are five times more likely to develop a serious complication due to oxygen supply problems therefore they are more likely to be admitted to intensive care units, where they may require mechanical ventilation. In the case of underlying COPD, the usual care plan for COVID-19 infection should be followed, as well as all public health recommendations to minimize the risk of developing and transmitting COVID-19.
Conclusion: Coronavirus infection is especially dangerous for COPD patients, who are much more likely to become seriously ill, so increased surveillance, prevention, early detection, adequate treatment and rehabilitation of the disease group are of paramount importance.
Keywords: COVID-19; SARS coronavirus; chronic obstructive pulmonary disease; complications; prevention.
. 2022 Feb 28.
doi: 10.1556/2060.2022.00172. Online ahead of print.
COVID-19 infection in patients with chronic obstructive pulmonary disease: From pathophysiology to therapy. Mini-review
Monika Fekete[SUP] 1 [/SUP], Zsofia Szarvas[SUP] 1 [/SUP], Vince Fazekas-Pongor[SUP] 1 [/SUP], Agnes Feher[SUP] 1 [/SUP], Norbert Dosa[SUP] 1 [/SUP], Andrea Lehoczki[SUP] 2 [/SUP], Stefano Tarantini[SUP] 1 3 [/SUP], Janos Tamas Varga[SUP] 4 [/SUP]
Affiliations
- PMID: 35230261
- DOI: 10.1556/2060.2022.00172
Abstract
Introduction: Patients with chronic obstructive pulmonary disease (COPD) are a vulnerable group in terms of the outcome of coronavirus infection in relation to their disease or its treatment, with a higher risk of developing serious complications compared to the healthy population.
Aim: The aim of our summary study is to review the background and health outcomes of chronic obstructive pulmonary disease and COVID-19 infection in the presence of both diseases.
Methods: Review of national and international medical databases (PubMed, MEDLINE, and MOB) with keywords COPD, COVID-19, disease risk, cause, prevention, complications, and prognosis.
Results: Meta-analyses show that COPD is one of the most common underlying conditions in patients hospitalized for COVID-19. Such patients are five times more likely to develop a serious complication due to oxygen supply problems therefore they are more likely to be admitted to intensive care units, where they may require mechanical ventilation. In the case of underlying COPD, the usual care plan for COVID-19 infection should be followed, as well as all public health recommendations to minimize the risk of developing and transmitting COVID-19.
Conclusion: Coronavirus infection is especially dangerous for COPD patients, who are much more likely to become seriously ill, so increased surveillance, prevention, early detection, adequate treatment and rehabilitation of the disease group are of paramount importance.
Keywords: COVID-19; SARS coronavirus; chronic obstructive pulmonary disease; complications; prevention.